Table 1 Baseline characteristics of study subjects
Variables | Alpha-linolenic plus L-carnitine group (n = 40) | Placebo group (n = 40) | P * | ||
|---|---|---|---|---|---|
Age (year) | 38.47 ± 5.70 | 39.17 ± 6.22 | 0.601 | ||
Weight (kg) | 73.63 ± 8.83 | 74.04 ± 7.44 | 0.824 | ||
Height (cm) | 165.48 ± 4.20 | 164.93 ± 4.97 | 0.595 | ||
BMI (kg/m2) | 26.89 ± 2.97 | 27.13 ± 1.40 | 0.651 | ||
SBP (mmHg) | 125.17 ± 11.41 | 124.35 ± 5.71 | 0.684 | ||
DBP (mmHg) | 80.23 ± 3.13 | 80.60 ± 3.94 | 0.645 | ||
Disease duration (year) | 5.07 ± 1.91 | 4.12 ± 2.37 | 0.052 | ||
Physical activity (MET/h/day) | 33.81 ± 4.26 | 32.08 ± 6.06 | 0.144 | ||
Migraine type | Episodic | 26 (65) | 24 (60) | 0.649 | |
Chronic | 14 (35) | 16 (40) | |||
Job | Housewife | 17 (42.5) | 19 (47.5) | 0.702 | |
Freelance | 10 (25) | 9 (22.5) | |||
Employee | 13 (32.5) | 12 (30) | |||
Education status | University graduated | 21 (52.5) | 24 (60) | 0.558 | |
Diploma | 12 (30) | 10 (25) | |||
Under diploma | 7 (17.5) | 6 (15) | |||
Marital status | Married | 28 (70) | 30 (75) | 0.622 | |
Single | 12 (30) | 10 (25) | |||
Familial history | Yes | 25 (62.5) | 29 (72.5) | 0.346 | |
No | 15 (37.5) | 11 (27.5) | |||
Medication | Beta-blockers | Yes | 28 (70) | 25 (62.5) | 0.484 |
No | 12 (30) | 15 (37.5) | |||
TCAs | Yes | 21 (52.5) | 17 (42.5) | 0.377 | |
No | 19 (47.5) | 23 (57.5) | |||
Benzodiazepine | Yes | 18 (45) | 16 (40) | 0.656 | |
No | 22 (55) | 24 (60) | |||
Sodium valproate | Yes | 10 (25) | 13 (32.5) | 0.456 | |
No | 30 (75) | 27 (67.5) | |||
NSAIDs | Yes | 21 (52.5) | 12 (30) | 0.041 | |
No | 19 (47.5) | 28 (70) | |||
Gabapentin | Yes | 14 (35) | 9 (22.5) | 0.222 | |
No | 26 (65) | 31 (77.5) | |||
Triptans | Yes | 7(17.5) | 4 (10) | 0.336 | |
No | 33 (82.5) | 36 (90) | |||
Topiramate | Yes | 6 (14) | 5 (12.5) | 0.749 | |
No | 34 (85) | 35 (87.5) | |||